Viemed Healthcare, Inc. (VMD): Capital Expenditures

Annual figures by period end, from SEC filings.

$39.98M
Year ended 2025-12-31
$31.55M
Trailing 12 months to 2026-06-30
+20.4%
3-year compound annual growth
+25.1%
5-year compound annual growth
2018-12-31: $6.11M2019-12-31: $13.38M2020-12-31: $13.04M2021-12-31: $19.74M2022-12-31: $22.90M2023-12-31: $26.09M2024-12-31: $37.77M2025-12-31: $39.98M$39.98M
2018-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$39.98M+5.9%2026-03-04, From 2025-01-01
2024-12-31$37.77M+44.8%2026-03-04, From 2024-01-01
2023-12-31$26.09M+14.0%2026-03-04, From 2023-01-01
2022-12-31$22.90M+16.0%2025-03-10, From 2022-01-01
2021-12-31$19.74M+51.4%2023-03-02, From 2021-01-01
2020-12-31$13.04M-2.5%2022-03-07, From 2020-01-01
2019-12-31$13.38M+118.9%2021-03-03, From 2019-01-01
2018-12-31$6.11Mn/a2020-03-04, From 2018-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Viemed Healthcare, Inc. (VMD)2025-12-31$39.98M+5.9%
Sotera Health Co (SHC)2025-12-31$138.02M-22.9%
Progyny, Inc. (PGNY)2025-12-31$18.41M+240.6%
Cryo Cell International Inc (CCEL)2025-11-30$230.5K-90.4%
agilon health, inc. (AGL)2025-12-31$13.24M-0.1%
Pacific Health Care Organization Inc (PFHO)2025-12-31$23.3K+154.9%
DaVita Inc. (DVA)2025-12-31$575.86M+3.7%
Charming Medical Ltd (MCTA)2026-03-31$339.6K+18.1%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$116.1K+9.3%

Compare VMD, SHC, PGNY, CCEL side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗